{"nct_id":"NCT02639247","title":"Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor","status":"COMPLETED","status_verified_date":"2017-10","start_date":"2015-12-23","start_date_type":"ACTUAL","primary_completion_date":"2016-10-05","primary_completion_date_type":"ACTUAL","completion_date":"2017-01-18","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}